CLINICAL_TRIALS
withdrawal
· 2025-06-05
Clinical Trial Update: A Study to Explore the Role of Gut Flora in ALS
Summary
This clinical trial evaluating the role of gut flora in amyotrophic lateral sclerosis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: ProgenaBiome | Conditions: ALS, Amyotrophic Lateral Sclerosis | Status: WITHDRAWN